SE8902170D0 - Therapeutically active compounds - Google Patents

Therapeutically active compounds

Info

Publication number
SE8902170D0
SE8902170D0 SE8902170A SE8902170A SE8902170D0 SE 8902170 D0 SE8902170 D0 SE 8902170D0 SE 8902170 A SE8902170 A SE 8902170A SE 8902170 A SE8902170 A SE 8902170A SE 8902170 D0 SE8902170 D0 SE 8902170D0
Authority
SE
Sweden
Prior art keywords
active compounds
therapeutically active
therapeutically
compounds
active
Prior art date
Application number
SE8902170A
Other languages
English (en)
Inventor
A E Braendstroem
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Priority to SE8902170A priority Critical patent/SE8902170D0/sv
Publication of SE8902170D0 publication Critical patent/SE8902170D0/sv
Priority to EG61989A priority patent/EG19302A/xx
Priority to IE405089A priority patent/IE64199B1/en
Priority to NZ231874A priority patent/NZ231874A/en
Priority to CA002005980A priority patent/CA2005980C/en
Priority to PH39731A priority patent/PH27446A/en
Priority to IL9279989A priority patent/IL92799A/en
Priority to GR890100833A priority patent/GR1000316B/el
Priority to AT90901073T priority patent/ATE110723T1/de
Priority to JP2501536A priority patent/JP2793905B2/ja
Priority to DE68917937T priority patent/DE68917937T2/de
Priority to HU901095A priority patent/HUT57204A/hu
Priority to AU48132/90A priority patent/AU639429B2/en
Priority to EP90901073A priority patent/EP0449935B1/en
Priority to US07/453,960 priority patent/US5025024A/en
Priority to PCT/SE1989/000739 priority patent/WO1990006924A1/en
Priority to KR1019900701827A priority patent/KR910700248A/ko
Priority to PT92649A priority patent/PT92649B/pt
Priority to YU242789A priority patent/YU47338B/sh
Priority to MYPI89001835A priority patent/MY129946A/en
Priority to CN89109589A priority patent/CN1028233C/zh
Priority to PL1989282922A priority patent/PL160767B1/pl
Priority to CS897343A priority patent/CS276361B6/cs
Priority to BG094657A priority patent/BG60101B2/bg
Priority to FI913034A priority patent/FI913034A0/fi
Priority to NO912414A priority patent/NO178336C/no
Priority to DK122191A priority patent/DK122191A/da
Priority to LVP-93-691A priority patent/LV10267B/lv

Links

SE8902170A 1988-12-22 1989-06-16 Therapeutically active compounds SE8902170D0 (sv)

Priority Applications (28)

Application Number Priority Date Filing Date Title
SE8902170A SE8902170D0 (sv) 1989-06-16 1989-06-16 Therapeutically active compounds
EG61989A EG19302A (en) 1988-12-22 1989-12-18 Compound with gastric acid inhibitory effect and process for its preparation
IE405089A IE64199B1 (en) 1988-12-22 1989-12-18 Compound with gastric acid inhibitory effect and process for its preparation
NZ231874A NZ231874A (en) 1988-12-22 1989-12-19 4-fluoro-2-(((4-methoxy-2-pyridinyl)methyl)sulphinyl)-1h-benzimidazole and pharmaceutical compositions
CA002005980A CA2005980C (en) 1988-12-22 1989-12-19 Benzimidazole derivative with gastric acid inhibitory effect and process for its preparation
PH39731A PH27446A (en) 1988-12-22 1989-12-19 Compound with gastric acid inhibitory effect
IL9279989A IL92799A (en) 1988-12-22 1989-12-19 History of benzimidazole, its preparation process and gastric acid-containing medicinal preparations
GR890100833A GR1000316B (el) 1988-12-22 1989-12-19 Μεθοδος για την παρασκευη μιας ενωσης με γαστρικη ανασταλτικη δραση.
KR1019900701827A KR910700248A (ko) 1988-12-22 1989-12-20 위산 분비 억제 효과를 갖는 화합물 및 그의 제조 방법
AU48132/90A AU639429B2 (en) 1988-12-22 1989-12-20 Compound with gastric acid inhibitory effect and process for its preparation
JP2501536A JP2793905B2 (ja) 1988-12-22 1989-12-20 胃酸抑制効果を有する化合物およびその製法
DE68917937T DE68917937T2 (de) 1988-12-22 1989-12-20 Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung.
HU901095A HUT57204A (en) 1988-12-22 1989-12-20 Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
AT90901073T ATE110723T1 (de) 1988-12-22 1989-12-20 Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung.
EP90901073A EP0449935B1 (en) 1988-12-22 1989-12-20 Compound with gastric acid inhibitory effect and process for its preparation
US07/453,960 US5025024A (en) 1988-12-22 1989-12-20 Therapeutically active fluoro-substituted compound
PCT/SE1989/000739 WO1990006924A1 (en) 1988-12-22 1989-12-20 Compound with gastric acid inhibitory effect and process for its preparation
CN89109589A CN1028233C (zh) 1988-12-22 1989-12-21 具有抑制胃酸作用的取代的苯并咪唑的制备方法
PT92649A PT92649B (pt) 1988-12-22 1989-12-21 Processo para a preparacao do 4-fluoro-2-< { (4-metoxi-2-piridinil)-metil}-sulfinil>-1h-benzimidazol e de composicoes farmaceuticas que o contem
YU242789A YU47338B (sh) 1988-12-22 1989-12-21 Novo jedinjenje 4-fluoro-2-// (4-metoksi-2-piridinil)metil-/sulfinil/- 1h-benzimidazol i postupak za njegovo dobijanje
MYPI89001835A MY129946A (en) 1988-12-22 1989-12-21 Compound with gastric acid inhibitory effect and process for its preparation.
PL1989282922A PL160767B1 (pl) 1988-12-22 1989-12-22 Sposób wytwarzania nowego 4-fluoro-2- [(4-metoksypirydynylo-2)metylosulfinylo]--1 H-benzimidazolu PL PL
CS897343A CS276361B6 (en) 1988-12-22 1989-12-22 4-fluoro-2-//(4-methoxy-2-pyridyl)methyl/sulfinyl/ -1h - benzimidazole, process for its production and a pharmaceutical comprising said compound as an active component
BG094657A BG60101B2 (bg) 1988-12-22 1991-06-19 Метод за получаване на 4-флуор-2-(((4-метокси-2- пиридинил)метил)тионил)-1н-бензимидазол
FI913034A FI913034A0 (fi) 1988-12-22 1991-06-20 Foerening med magsyrainhiberande effekt och foerfarande foer dess framstaellning.
NO912414A NO178336C (no) 1988-12-22 1991-06-20 Analogifremgangsmåte for fremstilling av en terapeutisk aktiv benzimidazolforbindelse og mellomprodukter
DK122191A DK122191A (da) 1988-12-22 1991-06-21 Benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme
LVP-93-691A LV10267B (en) 1988-12-22 1993-06-28 Compound with gastric acid inhibitory effect and process for its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8902170A SE8902170D0 (sv) 1989-06-16 1989-06-16 Therapeutically active compounds

Publications (1)

Publication Number Publication Date
SE8902170D0 true SE8902170D0 (sv) 1989-06-16

Family

ID=20376297

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8902170A SE8902170D0 (sv) 1988-12-22 1989-06-16 Therapeutically active compounds

Country Status (1)

Country Link
SE (1) SE8902170D0 (sv)

Similar Documents

Publication Publication Date Title
FI955939A (sv) Farmaceutiskt aktiva CNS-föreningar
DK85993A (da) 2-anilino-4-formyl-pyrimidinforbindelser
BA98296A (bs) Piperazinil-heterociklicna jedinjenja
KR910700249A (ko) 신규 치료학적 활성 화합물 및 그의 제조 방법
DK0396968T3 (da) Mejetærsker
DK1199307T3 (da) Farmaceutisk aktive benzoquinazolinforbindelser
IT1217573B (it) Benzammidi sostituite farmacologicamente attive
FI88825C (sv) Aktivt pansar
FI890123A0 (sv) Förfarande för framställning av terapeutiskt verksamma indolylpiperidinderivat
DK435688A (da) Farmaceutiske midler
FI901315A0 (sv) Arkformningsenhet
PT86766A (pt) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds
IT1229231B (it) Aminoimidazopiridine farmacologicamente attive
IT1221792B (it) Composti metossimetilici
DK0382318T3 (da) Overfladeaktiv forbindelse
DK0423802T3 (da) Phenoxyheterocycliske forbindelser
DK0400327T3 (da) Mejetærsker
SE8902170D0 (sv) Therapeutically active compounds
IT1173196B (it) Composti imidazopiridinici farmacologicamente attivi
SE8902584D0 (sv) New active compounds
ITMI921865A1 (it) Glicerofosfoderivati farmacologicamente attivi
SE8902195D0 (sv) New activ compounds
NO302815B1 (no) Terapeutisk aktive lignanforbindelser
IT1173197B (it) Composti imidazopiridinici farmacologicamente attivi
IT1173199B (it) Composti imidazopiridinici farmacologicamente attivi